Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

DNA methylation profiling in cancer.

Kondo Y, Issa JP.

Expert Rev Mol Med. 2010 Jul 28;12:e23. doi: 10.1017/S1462399410001559. Review.

PMID:
20663272
2.

Emerging technologies for genome-wide DNA methylation profiling in cancer.

Hatada I.

Crit Rev Oncog. 2006 Dec;12(3-4):205-23. Review.

PMID:
17425503
3.

Predicting aberrant CpG island methylation.

Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12253-8. Epub 2003 Sep 30.

4.

Dormant hypermethylated tumour suppressor genes: questions and answers.

Esteller M.

J Pathol. 2005 Jan;205(2):172-80. Review.

PMID:
15643671
5.

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.

Teodoridis JM, Strathdee G, Brown R.

Drug Resist Updat. 2004 Aug-Oct;7(4-5):267-78. Review.

PMID:
15533764
6.

Genome-wide DNA methylation profiles in precancerous conditions and cancers.

Kanai Y.

Cancer Sci. 2010 Jan;101(1):36-45. doi: 10.1111/j.1349-7006.2009.01383.x. Epub 2009 Oct 1. Review.

7.

Genome-wide analysis of epigenetics in cancer.

Lee MP.

Ann N Y Acad Sci. 2003 Mar;983:101-9. Review.

PMID:
12724215
8.

Detection and interpretation of altered methylation patterns in cancer cells.

Ushijima T.

Nat Rev Cancer. 2005 Mar;5(3):223-31. Review.

PMID:
15719030
9.

Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.

Shinjo K, Kondo Y.

Methods Mol Biol. 2012;863:221-39. doi: 10.1007/978-1-61779-612-8_13. Review.

PMID:
22359296
10.
11.

Genome-wide profiling of promoter methylation in human.

Hatada I, Fukasawa M, Kimura M, Morita S, Yamada K, Yoshikawa T, Yamanaka S, Endo C, Sakurada A, Sato M, Kondo T, Horii A, Ushijima T, Sasaki H.

Oncogene. 2006 May 18;25(21):3059-64.

PMID:
16407832
12.

General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.

Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C, Holler E, Andreesen R, Rehli M.

Cancer Res. 2010 Feb 15;70(4):1398-407. doi: 10.1158/0008-5472.CAN-09-3406. Epub 2010 Feb 9.

13.

The epigenetics of oral cancer.

Shaw R.

Int J Oral Maxillofac Surg. 2006 Feb;35(2):101-8. Epub 2005 Sep 8. Review.

PMID:
16154320
14.

DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.

Worm J, Guldberg P.

J Oral Pathol Med. 2002 Sep;31(8):443-9. Review.

PMID:
12220350
15.

Genome-wide analysis of DNA methylation changes in human malignancies.

Plass C, Smiraglia DJ.

Curr Top Microbiol Immunol. 2006;310:179-98. Review.

PMID:
16909911
16.

Aberrant DNA methylation in cancer: potential clinical interventions.

Strathdee G, Brown R.

Expert Rev Mol Med. 2002 Mar 4;4(4):1-17. Review.

PMID:
14987388
17.

Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.

Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M.

Cancer Res. 2006 Jun 15;66(12):6118-28.

18.

Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.

Clark SJ.

Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R88-95. Review.

19.

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S, Zhu J.

BMC Cancer. 2002 Nov 15;2:29. Epub 2002 Nov 15.

20.

Gene silencing by DNA methylation in haematological malignancies.

Boultwood J, Wainscoat JS.

Br J Haematol. 2007 Jul;138(1):3-11. Epub 2007 May 9. Review.

PMID:
17489980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk